Pay in 4 interest-free payments of $24.40 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
CBBR is an inhibitor of wild type and mutant alpha-synuclein aggregation and a modulator of neurotoxicity
This is consistent with previous reports indicating that Sotrastaurin inhibits ERK1/2 phosphorylation in GNAQ mutant cell lines
Antimicrob Agents Chemother
and MDA-MB-361 cells with IC50 of 46 nM
Vildagliptin 598 CBBR is an inhibitor ofVildagliptin (also known as LAF237 and Zomelis) is an oral anti hyperglycemic agent (anti diabetic drug) of the new dipeptidyl peptidase 4 (DPP 4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP 1 and GIP by DPP 4, allowing GLP 1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas. Vildagliptin has been shown to reduce
US$ 20.50
US$ 164.94
US$ 12.61